PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.\', \'Amyndas Pharmaceuticals, Glyfada, Greece.\', \'National Center for Scientific Research \'Demokritos\', Aghia Paraskevi, Athens, Greece.\', \'Institute of Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, Germany.\', \'IRCCS Humanitas Clinical and Research Center, Milan, Italy; Humanitas University, Milan, Italy.\', \'Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: lambris@pennmedicine.upenn.edu.\', \'Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; University Vita Salute San Raffaele, Milan, Italy. Electronic address: ciceri.fabio@hsr.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1521-6616(20)30331-410.1016/j.clim.2020.108450
?:doi
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 32360516
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The first case of COVID-19 treated with the complement C3 inhibitor AMY-101.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32360516>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32360516>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all